These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9112579

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Alteration of p15 and p16 gene in gastric cancer].
    Fushida S, Yonemura Y, Kawamura T, Nojima N, Satoh T, Fujita H, Michiwa Y, Fujimura T, Nishimura G, Miwa K, Miyazaki I.
    Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():279-84. PubMed ID: 9263516
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC, Kelsell DP, Hungerford JL, Cree IA.
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
    [Abstract] [Full Text] [Related]

  • 25. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors.
    Bahuau M, Vidaud D, Jenkins RB, Bièche I, Kimmel DW, Assouline B, Smith JS, Alderete B, Cayuela JM, Harpey JP, Caille B, Vidaud M.
    Cancer Res; 1998 Jun 01; 58(11):2298-303. PubMed ID: 9622062
    [Abstract] [Full Text] [Related]

  • 26. Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomas.
    Li YJ, Hoang-Xuan K, Delattre JY, Poisson M, Thomas G, Hamelin R.
    Oncogene; 1995 Aug 03; 11(3):597-600. PubMed ID: 7630644
    [Abstract] [Full Text] [Related]

  • 27. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status.
    Chaussade L, Eymin B, Brambilla E, Gazzeri S.
    Oncogene; 2001 Oct 04; 20(45):6587-96. PubMed ID: 11641784
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Infrequent somatic mutations of the p16 and p15 genes in human bladder cancer: p16 mutations occur only in low-grade and superficial bladder cancers.
    Miyamoto H, Kubota Y, Fujinami K, Dobashi Y, Kondo K, Yao M, Shuin T, Hosaka M.
    Oncol Res; 1995 Oct 04; 7(7-8):327-30. PubMed ID: 8747595
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Molecular analysis of the cyclin-dependent kinase inhibitor genes p15INK4b/MTS2, p16INK4/MTS1, p18 and p19 in human cancer cell lines.
    Gemma A, Takenoshita S, Hagiwara K, Okamoto A, Spillare EA, McMemamin MG, Hussain SP, Forrester K, Zariwala M, Xiong Y, Harris CC.
    Int J Cancer; 1996 Nov 27; 68(5):605-11. PubMed ID: 8938142
    [Abstract] [Full Text] [Related]

  • 32. Deletion and transfection analysis of the p15/MTS2 gene in malignant gliomas.
    Tenan M, Benedetti S, Finocchiaro G.
    Biochem Biophys Res Commun; 1995 Dec 05; 217(1):195-202. PubMed ID: 8526910
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
    Drexler HG.
    Leukemia; 1998 Jun 05; 12(6):845-59. PubMed ID: 9639410
    [Abstract] [Full Text] [Related]

  • 36. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P, Christodoulou P, Konstantinidou AE, Thomas-Tsagli E, Kapralos P, Davaris P.
    Hum Pathol; 2000 Jun 05; 31(6):751-60. PubMed ID: 10872671
    [Abstract] [Full Text] [Related]

  • 37. p16 (CDKN2/MTS1) gene deletions are rare in prostatic carcinomas in the United States and Japan.
    Mangold KA, Takahashi H, Brandigi C, Wada T, Wakui S, Furusato M, Boyd J, Chandler FW, Allsbrook WC.
    J Urol; 1997 Mar 05; 157(3):1117-20. PubMed ID: 9072554
    [Abstract] [Full Text] [Related]

  • 38. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS.
    Arch Otolaryngol Head Neck Surg; 2006 Apr 05; 132(4):409-15. PubMed ID: 16618910
    [Abstract] [Full Text] [Related]

  • 39. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
    Kanellou P, Zaravinos A, Zioga M, Spandidos DA.
    Br J Dermatol; 2009 Jun 05; 160(6):1215-21. PubMed ID: 19298278
    [Abstract] [Full Text] [Related]

  • 40. Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas.
    Bisogna M, Calvano JE, Ho GH, Orlow I, Cordón-Cardó C, Borgen PI, Van Zee KJ.
    Cancer Genet Cytogenet; 2001 Mar 05; 125(2):131-8. PubMed ID: 11369056
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.